UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 14, 2020 5:20 P.M.
Form:
S-1
CIK:
0001720725
Company Name:
Oyster Point Pharma, Inc.
File Number:
333-238194